Home/Filings/4/0001437749-22-009164
4//SEC Filing

GILLIS EDWARD M 4

Accession 0001437749-22-009164

CIK 0000925741other

Filed

Apr 17, 8:00 PM ET

Accepted

Apr 18, 9:16 PM ET

Size

7.1 KB

Accession

0001437749-22-009164

Insider Transaction Report

Form 4
Period: 2022-04-14
BioCardia, Inc.BCDA;BCDAW
GILLIS EDWARD M
Senior Vice President, Devices
Transactions
  • Award

    Stock Option (right to buy)

    2022-04-14+38,00038,000 total
    Exercise: $1.49Exp: 2032-04-14Common Stock (38,000 underlying)
  • Award

    Common Stock

    2022-04-14+30,15536,237 total
Footnotes (2)
  • [F1]The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on April 14, 2022.
  • [F2]The option vests and becomes exercisable as to 1/48th of the shares on May 14, 2022, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.

Issuer

BioCardia, Inc.

CIK 0000925741

Entity typeother

Related Parties

1
  • filerCIK 0001241359

Filing Metadata

Form type
4
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 9:16 PM ET
Size
7.1 KB